logo

For the Inventor, By the Inventor

Tokyo, Japan

National Institute of Infectious Diseases


USPTO Granted Patents = 35



Forward Citations = 61

Loading Chart...
Loading Chart...

132 inventors (with patents filed for the assignee):

goldMedal Takaji Wakita (9 out of 24 patents)

silverMedal Tatsuo Miyamura (6 out of 20 patents)

bronzeMedal Naokazu Takeda (4 out of 5 patents)

4.  Toshinori Sato (4 out of 6 patents)

5.  Katsuro Natori (4 out of 4 patents)

6.  Kunio Kamata (4 out of 5 patents)

7.  Seiya Sato (4 out of 4 patents)

8.  Tetsuya Uchida (3 out of 15 patents)

9.  Yoshimasa Takahashi (3 out of 12 patents)

10.  Reiko Todaka (2 out of 2 patents)

11.  Kazuhiko Katayama (2 out of 16 patents)

12.  Motohiro Miki (2 out of 8 patents)

13.  Yuko Sasaki (2 out of 36 patents)

14.  Taizou Kamishita (2 out of 8 patents)

15.  Kazuhiro Matsuda (2 out of 7 patents)


35 patents:

1. 12508251 - CD4 mimic compound with anti-HIV activity (2025-12-30),
2. 12059462 - Composition containing influenza vaccine (2024-08-13),
3. 11732031 - Method for producing influenza HA split vaccine (2023-08-22),
4. 11517616 - Composite polypeptide monomer, aggregate of said composite polypeptide monomer having cell penetration function, and norovirus component vaccine for subcutaneous, intradermal, percutaneous, or intramuscular administration and having said aggregate as effective component thereof (2022-12-06),
5. 11491219 - Nasal hepatitis B vaccine composition and method for producing same (2022-11-08),
6. 11384172 - Polymer, antimicrobial agent, disinfectant, antimicrobial material, disinfectant material, antimicrobial method, and disinfecting method (2022-07-12),
7. 11299750 - Cultured transgenic cell allowing growth of norovirus, and use thereof (2022-04-12),
8. 10532201 - Drug administration device, and manufacturing method for drug administration device (2020-01-14),
9. 10232026 - Vaccine for mycoplasma infection (2019-03-19),
10. 9814785 - Hepatitis C virus liposome vaccine (2017-11-14),
11. 9603919 - Method for prophylaxis of influenza using vaccine for intranasal administration (2017-03-28),
12. 9539209 - Vaccine for mycoplasma infection (2017-01-10),
13. 9453056 - Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 3a (2016-09-27),
14. 9234184 - Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 1B, hepatitis C virus genome-replicating cells transfected with the same, and method for producing infectious hepatitis C virus particles (2016-01-12),
15. 9186383 - Mutant replicon derived from genome of hepatitis C virus J6CF strain (2015-11-17),
The National Institute of Infectious Diseases (NIID) in Japan is a leading research institute specializing in the study and prevention of infectious diseases. With a mission to control infectious diseases and protect public health, NIID conducts research, provides training, and collaborates with national and international partners to combat infectious diseases effectively.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

35 Patents

#865 in Tokyo

#2,077 in Japan

#18,625 in the World

...
Tokyo, Japan

National Institute of Infectious Diseases

Forward Citations = 61

132 inventors:

goldMedal Takaji Wakita (9 out of 24 patents)

silverMedal Tatsuo Miyamura (6 out of 20 patents)

bronzeMedal Naokazu Takeda (4 out of 5 patents)

4.  Toshinori Sato (4 out of 6 patents)

5.  Katsuro Natori (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…